Related by context. All words. (Click for frequent words.) 80 Drug Candidate 79 Therapeutic Potential 78 Combination Treatment 78 Preclinical Data 77 Prolongs Survival 77 Phase 2b Clinical Trial 77 Mouse Model 77 Anti Tumor 76 Investigational Treatment 76 Oral Fingolimod 76 Phase 2a Trial 76 Inflammatory Markers 76 Demonstrates Efficacy 76 Kinase Inhibitor 76 Gene Mutation 76 RNAi Therapeutics 76 Epidermal Growth Factor Receptor 76 Therapeutic Antibody 76 Investigational Drug 76 Insulin Resistance 75 Protein Involved 75 Novel Oral 75 Phase 2b Trial 75 Fungal Infections 75 Pulmonary Arterial Hypertension 75 Drug Resistant 75 Clinical Trial Results 75 Pooled Analysis 75 Drug Shows Promise 75 Antitumor Activity 75 Lung Cancers 75 Meets Primary Endpoint 75 Skeletal Muscle 75 Novel Antibiotic 75 Shown Effective 75 JAK Inhibitor 75 Breast Cancer Cells 75 Study Evaluating 75 Gene Linked 75 Effectively Treats 75 RNAi Therapeutic 75 Tumor Growth 75 Phase 2a Clinical Trial 75 Tumor Suppressor 75 Signaling Pathway 75 Statistically Significant 75 Renal Cell Carcinoma 74 Breast Cancer Metastasis 74 Novel Therapeutic 74 Gout Drug 74 Protein Linked 74 Tyrosine Kinase Inhibitor 74 Receptor Agonist 74 Genetic Variation 74 Knee Osteoarthritis 74 Epilepsy Drug 74 Genetic Mutation 74 Genetic Variant 74 Radiation Induced 74 Present Preclinical Data 74 Inhibits 74 Viral Infections 74 Preclinical Study 74 Drug Combo 74 Dendritic Cells 74 Improves Survival 74 Shows Promising 74 Hormone Receptor Positive 74 Systemic Delivery 74 Monoclonal Antibody 74 Gene Mutations 74 Immune Cell 74 Genes Linked 74 Drug Prevents 74 Presents Preclinical Data 74 Clinical Outcome 74 Anticancer Activity 74 Adjuvant Chemotherapy 74 Gene Variant 74 Improves Outcomes 74 Controlled Trial 74 Inhaled Corticosteroids 74 Demonstrates Potent 74 Cholesterol Lowering Drug 74 Hypertensive Patients 74 Tumor Targeting 73 Mimetics 73 Relapsing Multiple Sclerosis 73 Receptor Antagonist 73 Therapeutic Effects 73 Small Molecule 73 Previously Treated 73 Patients Receiving 73 Increased Mortality 73 Factor Receptor 73 Shows Promise Against 73 Unfractionated Heparin 73 Antiviral Drugs 73 Investigational Compound 73 Phase 2b Study 73 Interferon Beta 73 Treating Chronic 73 Recombinant Human 73 Gene Variation 73 Diabetic Nephropathy 73 Pediatric Patients 73 Meta Analysis 73 Therapeutic Efficacy 73 Lung Cancer Drug 73 Antitumor 73 Investigational Agent 73 Significantly Improved 73 Protease Inhibitor 73 Anti Tumor Activity 73 Gene Variants 73 Kidney Transplant Patients 73 Immune Responses 73 Cell Adhesion 73 Critically Ill Patients 73 Inflammatory Disease 73 Elderly Patients 73 Chronic Inflammation 73 Leukemia Cells 73 Progenitor Cells 73 See CLINICAL PHARMACOLOGY 73 Hematological Cancers 73 Anticancer Agent 73 Well Tolerated 73 Osteoporosis Drug 73 Septic Shock 73 Phase III Clinical Trial 73 Prostate Cancer Patients 73 Beneficial Effects 73 Autoimmune Disease 73 Long Term Efficacy 73 Pharmacokinetic Study 72 Genes Associated 72 Phase IIb Trial 72 Diabetic Neuropathy 72 Disease Progression 72 Trial Evaluating 72 Immune Cells 72 Inflammatory Diseases 72 Tumor Necrosis Factor 72 Genetic Disorder 72 Angiogenic 72 TNF Blockers 72 Autoimmune Diseases 72 Slow Progression 72 Demonstrates Positive 72 Prophylactic Treatment 72 Survival Benefit 72 Multiple Myeloma Patients 72 Vaccine Candidate 72 Resistant Hypertension 72 Attenuates 72 Molecular Mechanism 72 Fracture Risk 72 Thyroid Hormone 72 Effective Treatments 72 Orally Active 72 Cocaine Addiction 72 Vaccine Protects Against 72 Blood Pressure Drug 72 Smooth Muscle 72 Cancer Cells 72 Completes Patient Enrollment 72 Subgroup Analysis 72 Signaling Pathways 72 Stem Cell Treatment 72 Phase IIb Clinical Trial 72 Randomized Phase 72 Advanced Melanoma 72 Osteoporosis Treatment 72 Breast Cancer Recurrence 72 Subtypes 72 Monotherapy 72 Insulin Glargine 72 Cerebrospinal Fluid 72 Elevated Levels 72 Topical Treatment 72 Low Dose 72 Initiates Clinical Trial 72 Controlled Study 72 FDA Okays 72 Novel Compound 72 Potentially Fatal 72 Anticancer Drug 72 Breast Tumors 72 Anti Angiogenic 72 Tumor Suppressor Gene 72 Cancer Stem Cells 72 Inflammatory Arthritis 72 Treatment Regimen 72 Predict Risk 72 Prostate Cancer Vaccine 72 Skin Lesions 72 Brain Cells 72 Potent Antiviral Activity 72 Genetic Variations 72 Double Blind Placebo 72 Appears Safe 72 Patients Treated With 72 Lupus Drug 72 Novel Inhibitor 71 First Patient Dosed 71 Patients Suffering 71 Replacement Therapy 71 Improve Survival 71 Study Demonstrates 71 Lowers Risk 71 Preterm Delivery 71 Uric Acid 71 Cholesterol Drug 71 Fewer Side Effects 71 Hepatocellular Carcinoma 71 Rheumatoid Arthritis Patients 71 Suppresses 71 Iron Deficiency 71 Aurora Kinase 71 Therapy Improves 71 Malignant Glioma 71 Menopausal Women 71 Bone Marrow Stem Cells 71 Immunomedics Announces 71 Proven Effective 71 Colorectal Cancer Patients 71 Anti Clotting Drug 71 Receives Orphan Drug Designation 71 Induces 71 Severe Asthma 71 NMDA Receptor 71 Liver Injury 71 Virus Infection 71 Heart Failure Patients 71 Allergic Rhinitis 71 Placebo Controlled Study 71 Is Well Tolerated 71 Proves Effective 71 Prostate Tumors 71 Synthetic Peptide 71 Kinase Inhibitors 71 Cardiovascular Outcomes 71 Antiangiogenic 71 DNA Methylation 71 Aliskiren 71 Neural Stem Cells 71 AnaSpec Introduces 71 Slows Progression 71 Treatment Shows Promise 71 Neuroprotective Effects 71 Hypercholesterolemia 71 Teva Provides Update 71 Transcription Factor 71 Myeloma Patients 71 Interferon Gamma 71 Improved Survival 71 IND Application 71 Immunomodulatory 71 Cell Transplants 71 Anthracycline 71 Levels Linked 71 Estrogen Receptor 71 Thrombotic 71 Mouse Models 71 Treatment Naive Patients 71 Gastric Cancer 71 Initiates Clinical 71 Advanced Renal Cell 71 Epilepsy Drugs 71 Receptor Antagonists 71 Prospective Randomized 71 Impairs 71 Atopic Dermatitis 71 Potent Inhibitor 71 Hematological Malignancies 71 Non Invasive Treatment 71 Prognostic Factors 71 Liver Toxicity 71 Dose Response 71 Biomarker Study 71 Breast Cancers 71 Chronic Hepatitis C 71 Nicotine Vaccine 71 Combo Therapy 71 Cholesterol Lowering 71 Treatment Reduces 71 Cannabinoid 71 Newly Diagnosed Multiple Myeloma 71 JAK2 Inhibitor 71 Circulating Tumor Cells 71 NDA Submission 71 Phase IIa Clinical Trial 71 Develop Novel 71 Drug Fails 71 Minimally Invasive Treatment 71 Hepatitis C Treatment 71 Chemotherapeutic Agents 71 Preclinical Models 70 Successfully Completes Phase 70 Anti Inflammatory Drug 70 Novel Method 70 Transdermal Patch 70 Phenotypes 70 Liver Tumors 70 Bavituximab 70 Beta Blocker 70 Renal Impairment 70 Atypical Antipsychotic 70 Aggressive Prostate Cancer 70 Sustained Efficacy 70 Shows Efficacy 70 Neoadjuvant Chemotherapy 70 Anti Angiogenesis 70 Epileptic Seizures 70 Refractory Hodgkin Lymphoma 70 Serious Infections 70 Transplant Patients 70 Complicated Skin 70 Combination Therapy 70 Anticancer Drugs 70 Hsp# Inhibitor 70 Protein Kinase 70 Antiviral Activity 70 Experimental Vaccine 70 Genes Identified 70 Oral Mucositis 70 HDAC Inhibitor 70 HER2 Positive 70 Statin Therapy 70 Myelodysplastic Syndromes 70 Statin Drugs 70 Adjuvant Treatment 70 Rotavirus Vaccine 70 Vaccine Adjuvant 70 Newly Diagnosed 70 Reduced Risk 70 Obesity Linked 70 FDA Accepts 70 Migraine Headaches 70 Advanced Ovarian Cancer 70 Test Detects 70 Infected Patients 70 Single Dose 70 Efficacious 70 Novel Treatments 70 Iron Overload 70 Seasonal Influenza Vaccine 70 Tumor Cells 70 FDA Approvals 70 Blood Thinner 70 Sleep Disturbances 70 Significantly Improves 70 Arthritis Drug 70 Chronic Hepatitis B 70 Muscle Function 70 Chronic Myeloid Leukemia 70 Localized Prostate Cancer 70 Advanced Prostate Cancer 70 Amniotic Fluid 70 Renal Function 70 Tezampanel 70 Breast Cancer Stem Cells 70 Diabetic Foot Ulcer 70 Polymerase Inhibitor 70 Presents Positive 70 Respiratory Virus 70 Neuroprotection 70 Double Blind Randomized 70 Clinical Efficacy 70 Cyclooxygenase 2 70 Premature Aging 70 Metastatic Prostate Cancer 70 Transdermal Delivery 70 Kidney Function 70 Demonstrated Significant 70 Genetic Mutations 70 Therapeutic Vaccines 70 Successfully Treated 70 Allogeneic 70 Premature Infants 70 Demonstrates Potential 70 Adjuvant Therapy 70 Leukemias 70 Novel Anti Inflammatory 70 Osteoporosis Drugs 70 Fallopian Tube 70 Orthostatic Hypotension 70 Glucocorticoid 70 Immune Mediated 70 Treated Patients 70 Liver Failure 70 Node Positive 70 Initiate Phase 70 Cigarette Smoke 70 Nerve Cells 70 Molecular Basis 70 Insulin Sensitivity 70 Obese Patients 70 Hormone Refractory Prostate Cancer 70 Hepatitis C Virus 70 Viral Infection 70 Files IND 70 Hepatitis C Infection 70 Decitabine 70 Novel Compounds 70 Initiates Phase III 70 Cell Proliferation 70 Aptamer 70 Prenatal Exposure 70 Initiate Clinical Trial 70 Cognitive Impairment 70 Brain Scans 70 Fibrinogen 70 Malaria Vaccine 70 Advanced Pancreatic Cancer 70 Lung Cancer Survival 70 Bacterial Infections 70 Overactive Bladder 70 Tiotropium 70 Antisense Drug 70 Patient Enrollment 70 Modulates 70 Dehydrogenase 70 Glatiramer Acetate 70 Antigen Specific 70 Phospholipase A2 69 Dose Escalation 69 Male Contraceptive 69 Autologous Stem Cell Transplantation 69 Stem Cell Transplants 69 Fat Cells 69 Respiratory Infections 69 Safinamide 69 Cardiac Function 69 Collaborators Present 69 Demonstrates Significant 69 Blood Clotting 69 Potent Anti 69 Immunotherapeutic 69 Gene Silencing 69 Completes Enrollment 69 Cell Differentiation 69 Antifungal 69 Trodusquemine MSI 69 Clinical Trial Data 69 Romidepsin 69 Proteasome 69 Pre Eclampsia 69 Therapy Shows Promise 69 Adverse Effects 69 Vascular Inflammation 69 Enlarged Prostate 69 Secondary Hyperparathyroidism 69 Left Ventricular 69 Inhaled Nitric Oxide 69 Genes Involved 69 Protein Synthesis 69 ACE Inhibitors 69 Artery Disease 69 Pafuramidine 69 Metabolites 69 Integrase Inhibitor 69 Cholesterol Drugs 69 TNF Alpha 69 Oncolytic 69 Chronic Sinusitis 69 Therapeutic Vaccine 69 Histone Deacetylase 69 Smallpox Vaccine 69 Increased Risk 69 Metastatic Melanoma 69 Placebo Controlled Trial 69 Bacterial Infection 69 FDA Approves Drug 69 Submits NDA 69 Endothelial Cells 69 Psoriasis Drug 69 Vaccine Shows Promise 69 Androgen Receptor 69 Pegylated 69 Pivotal Phase 69 Antidepressant Drug 69 Protein Interactions 69 Oral Calcitonin 69 Postmenopausal Osteoporosis 69 Phase III Trials 69 Fibromyalgia Pain 69 Adjunctive Therapy 69 Brain Shrinkage 69 Study Shows Benefits 69 Unresectable 69 Early Diagnosis 69 Muscle Wasting 69 familial amyloidotic polyneuropathy FAP 69 Preclinical Evaluation 69 Antithrombin 69 Study Shows Promise 69 Lung Infections 69 Kidney Transplant Recipients 69 Antisense Oligonucleotides 69 Receives Orphan Drug 69 Cognitive Function 69 Metastatic Colorectal Cancer 69 Patients Undergoing 69 Diabetic Patients 69 Genes Predict 69 Inhaled Steroids 69 Often Misdiagnosed 69 Granted Orphan Drug 69 Preclinical Efficacy 69 Lymphoid 69 Periodontal Disease 69 Severe Sepsis 69 Virus Linked 69 Ischemic 69 Phase III Trial 69 Female Sexual Arousal 69 Brain Tumors 69 Lung Cancer Patients 69 Progressive Multifocal Leukoencephalopathy 69 Contrast Agents 69 Venous Thrombosis 69 Oral Formulation 69 Metabolic Disorder 69 Dengue Virus 69 Stomach Cancer 69 Denufosol 69 Antiplatelet 69 Anti Inflammatory 69 Benign Prostatic Hyperplasia 69 Malignant Melanoma 69 Hepatitis B Virus 69 TB Vaccine 69 Patients Treated 69 Novel Therapies 69 Solid Tumors 69 II Clinical Trial 69 Disease Modifying 69 Drug Resistant Bacteria 69 Kidney Failure 69 Demonstrates Sustained 69 Bone Marrow Cells 69 Migraine Drug 69 Liver Damage 69 Visceral Fat 69 Therapeutic Targets 69 Novel Small Molecule 69 Radiofrequency Ablation 69 Cardiovascular Events 69 Tumor Progression 69 Cardiotoxicity 69 Randomized Double Blind 69 Anticancer 69 Prognostic Value 69 Allergic Reactions 69 Phase 1b Clinical Trial 69 Epratuzumab 69 Bone Metastases 69 Reductase 69 Induces Apoptosis 69 Skin Disorders 69 Cancer Recurrence 69 Schizophrenia Treatment 69 Advanced Colorectal Cancer 69 Panic Disorder 69 Improve Outcomes 69 Confirmatory Phase 69 Vitro Activity 69 Acute Heart Failure 69 Fondaparinux 69 Castration Resistant Prostate Cancer 69 Randomized Double blind 69 Prognostic Significance 69 Diabetic Neuropathic Pain 68 Renal Cancer 68 Lung Cancer Trial 68 Genetic Markers 68 Asthma Treatment 68 Gastrointestinal Disorders 68 Venous Thromboembolism 68 Relapsed Refractory 68 Preterm Labor 68 Recombinant Protein 68 Systematic Review 68 Data Suggest 68 Polymorphisms 68 Antidepressants Linked 68 Postmenopausal Women 68 Inhaled Liposomal Ciprofloxacin 68 Randomized Double Blind Placebo 68 Cognitive Deficits 68 Golimumab 68 Novel Peptide 68 Conjugated 68 Myelofibrosis 68 Rheumatoid Arthritis Drug 68 Reduces Risk 68 Universal Flu Vaccine 68 Androgen 68 Naturally Occurring 68 Clinical Trial Evaluating 68 Fixed Dose 68 Bipolar Mania 68 Sustained Release 68 Certain Cancers 68 Mesothelioma Treatment 68 Influenza Virus 68 Antibiotic Resistance 68 Hepatitis B Vaccine 68 Respiratory Distress 68 Erythropoietic 68 Adenoma 68 Cytotoxicity 68 Renal Anemia 68 Chronic Cough 68 Milestone Payment 68 Osteoarthritis Patients 68 Anemia Drug 68 MMR Vaccine 68 Blood Cancers 68 AVI BioPharma Announces 68 Chronic Lymphocytic Leukemia 68 Hedgehog Pathway 68 Antipsychotic Drug 68 Autoimmune Disorders 68 Cognitive Decline 68 Long Term Survival 68 Nerve Regeneration 68 Treatment Experienced 68 Inactivation 68 Phase Ib Clinical Trial 68 Antipsychotic 68 Novel Approach 68 Calcium Supplements 68 Schizophrenia Drug 68 Nucleoside 68 Neuroprotective 68 Gum Disease 68 CYP#A# CYP#D# 68 Monoclonal 68 Endometrial Cancer 68 Avian Flu Vaccine 68 Cancer Vaccines 68 Prostate Cancers 68 Wound Dressings 68 Anticoagulant 68 Prostate Cancer Treatment 68 Lupus Nephritis 68 Antibiotic Resistant 68 Ovarian Cancer Patients 68 Genotypes 68 B Cell Malignancies 68 Scientists Identify 68 Irritable Bowel 68 Pharmacodynamics 68 Abdominal Fat 68 Laryngeal Cancer 68 Treat Anemia 68 Analogs 68 Oral Anticoagulant 68 Targeted Therapies 68 Peptic Ulcer 68 Clostridium difficile Infection 68 Mg Usa 68 Confirms Efficacy 68 Researchers Identify 68 Menopausal Symptoms 68 Pivotal Phase III 68 Showed Significant 68 HCV Protease Inhibitor 68 Prove Effective 68 Initiate Phase III 68 Erectile Dysfunction Drug 68 Study Sheds Light 68 Generic Version 68 Therapeutic Agents 68 Invasive Fungal Infections 68 Muscle Cells 68 Immunosuppression 68 Commonly Prescribed 68 Neovascular Age Related Macular 68 Colorectal Adenomas 68 Demonstrates Statistically Significant 68 Conjugate 68 Initiates Phase II 68 Relapsed Multiple Myeloma 68 BiTE Antibody 68 Increases Risk 68 Chemokine Receptor 68 Receives Milestone Payment 68 Brain Metastases 68 Antiplatelet Therapy 68 Clinical Evaluation 68 Hematopoietic Stem Cell Transplantation 68 Cardiovascular Mortality 68 Blood Pressure Drugs 68 Extended Release 68 Pulmonary Artery 68 Angiotensin II 68 Epithelial 68 Plaque Psoriasis 68 Substantially Reduce 68 Study Casts Doubt 68 Histone 68 Chronic Bronchitis 68 Protease Inhibitors 68 Hospitalized Patients 68 Patent Covering 68 Testosterone Patch 68 Treating Depression 68 Skin Condition 68 Vitamin D Deficiency 68 Cancer Treatments 68 Drug Coated Stents 68 Tesamorelin 68 Cell Transplant 68 Acute Ischemic Stroke 68 Inhibitor 68 Sapacitabine 68 Human Monoclonal Antibody 68 Protein Kinase Inhibitors 68 Blood Clots 68 Pregnancy Linked 68 Multidrug Resistant 68 Significantly Reduced 68 Helps Identify 68 Treatment Naïve 68 Efficacy Trial 68 Malignancy 68 Macrophage 68 Fulvestrant 68 Antibody Drug Conjugate 68 Peginterferon 68 Lymphocytic 68 Hormone Therapy 68 Enzyme Replacement Therapy 68 selective modulator 68 protein tyrosine phosphatase 1B 68 Adenoma Prevention 68 Bipolar Depression 68 Inflammatory Response 67 Plus Ribavirin 67 Thiazolidinediones 67 Cytotoxic 67 Left Ventricular Hypertrophy 67 Regenerative Cells 67 Randomized Controlled Trial 67 Bevacizumab 67 Therapeutic Antibodies 67 Estrogen Therapy 67 Cognitive Problems 67 Blood Vessels 67 Disease IBD 67 Acne Drug 67 Stem Cell Procedure 67 Ebola Virus 67 Severe Acne 67 Bosutinib 67 Aztreonam Lysine 67 Blood Clot Risk 67 Rare Genetic 67 Earns Milestone Payment 67 Endothelial Function 67 First Patient Enrolled 67 Predict Prostate Cancer 67 Sipuleucel T 67 Non Alcoholic Fatty 67 Shows Promise 67 Data Indicate 67 ALN HPN 67 Immunostimulatory 67 Ovarian Cancers 67 Anti Inflammatory Drugs 67 Electrical Stimulation 67 Breast Cancer Treatment 67 Blocked Arteries 67 PKC# 67 Endoplasmic Reticulum 67 Small Molecules 67 Recurrent Breast Cancer 67 Chronic Pelvic Pain 67 Transplant Recipient 67 Beta Blockers 67 Randomized Controlled Trials 67 Oral Cavity 67 Diagnostic Tests 67 Chemotherapy Induced 67 Rheumatoid 67 HER2 Positive Breast Cancer 67 Sex Hormones 67 Metabolic Disease 67 Anti Nausea 67 Heartburn Drugs 67 Therapy Reduces 67 Fabry Disease 67 Circadian Clock 67 Allergic Asthma 67 Commonly Used 67 Initiates Phase 67 Secretion 67 Combination REOLYSIN R 67 Metastatic Renal Cell Carcinoma 67 Novel Vaccine 67 Brain Plasticity 67 Cholesterol Lowering Drugs 67 Myocardial Ischemia 67 Inhibitors 67 Device Helps 67 Gout Patients 67 Coronary Arteries 67 Viral Suppression 67 Tolerability 67 Colon Polyps 67 Retinoic Acid 67 Bucindolol 67 Brain Atrophy 67 IND Filing 67 Synaptic Plasticity 67 Valvular Heart Disease 67 Malignancies 67 Reperfusion Injury 67 Oxidative Stress 67 Malaria Parasite 67 Peginterferon Alfa 2a 67 Neurotoxicity 67 Intravenous Formulation 67 Prodrug 67 Treatment Resistant 67 Cytochrome P# 67 Mylan Receives Approval 67 Long Term Outcomes 67 Transcriptome 67 Metastases 67 Randomized Trials 67 Hormonal Therapy 67 Achieves Primary Endpoint 67 Transcriptional 67 Cold Sores 67 Nymox NX 67 Urine Test 67 Hematopoietic 67 FDA APPROVES 67 Angioedema 67 PEGylated Fab fragment 67 TNF Tumor Necrosis Factor 67 Hyperkalemia 67 Seasonal Allergies 67 Metastatic Cancer 67 Idiopathic Pulmonary Fibrosis 67 Being Studied 67 Kidney Transplants 67 Guidelines Issued 67 Tumor Cell 67 Breast Tumor 67 Drug Combinations 67 Newly Identified 67 Less Invasive 67 Hepatocytes 67 Suicidality 67 Patients Enrolled 67 Randomized Clinical Trial 67 Lung Tumor 67 Novel Protein 67 FDA Panel Recommends 67 Multicenter Trial 67 Polymorphism 67 Urinary Incontinence 67 Carotid Stenting 67 Phase III Clinical Trials 67 CYT# potent vascular disrupting 67 Cutaneous T 67 Acute Pancreatitis 67 Effective Than 67 Treatment Naïve Patients 67 Bile Acid 67 Begin Clinical Trials 67 Vicriviroc 67 Methylnaltrexone 67 Prostate Cancer Cells 67 Predict Response 67 Antibiotic Use 67 Helps Predict 67 Vaccine Adjuvants 67 Lowers Blood Pressure 67 Maribavir 67 Calcium Vitamin D 67 Artificial Pancreas 67 EntreMed Presents 67 Study Showed 67 Antimalarial 67 Autoantibodies 67 Significant Improvements 67 Brain Function 67 Asthma Attacks 67 Growth Hormone Deficiency 67 Pain Relievers 67 Nicotine Addiction 67 pralatrexate injection folate analogue 67 Intracellular 67 Skin Cells 67 Differentially 67 Study Proves 67 Renal Tumors 67 Reduces Pain 67 Adenoviral 67 Abnormality 67 Bladder Cancer 67 Gender Differences 67 Prospective Multicenter 67 Granulocyte Colony Stimulating Factor 67 Psychiatric Disorders 67 Childhood Leukemia 67 Lipid Levels 67 Drug Induced 67 Initiates Dosing 67 von Willebrand Factor 67 Herpes Virus 67 Pneumonia Vaccine 67 Potentially Deadly 67 Sustained Reduction 67 Androgen Deprivation Therapy 67 PEGylated anti 67 Inhibit 67 Phase 2a Study 67 Blood Vessel 67 Premenopausal Women 67 Antidepressant Use 67 Excessive Sweating 67 Voreloxin 67 SARS Virus 67 Study Reinforces 67 Acute Exacerbations 67 Embryonic Stem Cells 67 CNS Disorders 67 Pivotal Trials 67 Prolongs Life 67 Anthrax Toxin 67 Ischemic Stroke 66 Asthma Symptoms 66 Reduces Mortality 66 Sangamo BioSciences Announces 66 Murine Model 66 Diagnostic Criteria 66 Controlled Clinical Trial 66 Refractory Angina 66 Hospital Acquired Pneumonia 66 Treating Heart Failure 66 Hepatic Encephalopathy 66 Hematological 66 Ebola Vaccine 66 Nebulized 66 Findings Suggest 66 Inherited Diseases 66 Prevent Breast Cancer 66 Symptom Relief 66 Vertebral Fractures 66 Obese Teens 66 Versus Placebo 66 Homeostasis 66 Antigens 66 Mental Decline 66 Dose Ranging Study 66 Assay Kits 66 Improve Diagnosis 66 Glufosfamide 66 Lung Injury 66 Genetic Marker 66 Oral Presentations 66 Community Acquired Pneumonia 66 Antipsychotic Drugs 66 Pharmacokinetics PK 66 Lung Cancer Treatment 66 Progenitor Cell 66 Randomized Study 66 Solid Tumor 66 Cervical Cancer Vaccine 66 Lung Function 66 Gram Positive 66 Janus kinase 66 Hemodialysis Patients 66 Chemotherapy Regimen 66 Pivotal Study 66 Heart Defects 66 Platelet Derived Growth 66 Lubiprostone 66 Human Neural Stem 66 Thromboembolism 66 ACER paper 66 Humanized Anti 66 Placebo Effect 66 Vitamin D Linked 66 Blood Stem Cells 66 Preterm Infants 66 Holds Promise 66 Collaborators Publish 66 Monoclonal Antibodies 66 Acute Liver Failure 66 Prolonged Survival